These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25546212)

  • 1. Atypical Parkinsonian syndromes with very poor striatal uptake on 123I-ioflupane SPECT imaging.
    Dibble EH; Yoo DC; Noto RB; Friedman JH
    Clin Nucl Med; 2015 Feb; 40(2):e152-6. PubMed ID: 25546212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing the Diagnosis of Parkinsonian Syndromes With
    Banks KP; Peacock JG; Clemenshaw MN; Kuo PH
    AJR Am J Roentgenol; 2019 Aug; 213(2):243-253. PubMed ID: 30995085
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of 123I-Ioflupane SPECT in Patient Management: Essential Tremor.
    Dellavedova L; Giorgetti A; Maffioli LS
    Clin Nucl Med; 2016 Mar; 41(3):e154-5. PubMed ID: 26447386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders.
    Nuvoli S; Spanu A; Piras MR; Nieddu A; Mulas A; Rocchitta G; Galleri G; Serra PA; Madeddu G
    Medicine (Baltimore); 2017 May; 96(21):e6967. PubMed ID: 28538394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of dopamine transporter single photon emission computed tomography imaging using I-123 ioflupane on diagnoses of patients with parkinsonian syndromes.
    Bairactaris C; Demakopoulos N; Tripsianis G; Sioka C; Farmakiotis D; Vadikolias K; Heliopoulos I; Georgoulias P; Tsougos I; Papanastasiou I; Piperidou C
    J Clin Neurosci; 2009 Feb; 16(2):246-52. PubMed ID: 19097795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Undetectable specific striatal [¹²³I]-ioflupane binding in patients with parkinsonism.
    Petyt G; Kreisler A; Demailly F; Olivier A; Defebvre L; Semah F
    J Neurol Sci; 2014 Jun; 341(1-2):167-71. PubMed ID: 24814162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of 123I-ioflupane and 123I-iodobenzamide SPECT scans in 248 patients with parkinsonian syndromes.
    Vlaar AM; de Nijs T; Kessels AG; Vreeling FW; Winogrodzka A; Mess WH; Tromp SC; van Kroonenburgh MJ; Weber WE
    Eur Neurol; 2008; 59(5):258-66. PubMed ID: 18264015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential alterations of dopamine transporter in the striatum and midbrain in patients with parkinsonian syndrome.
    Matesan MC; Cross DJ; Lewis DH; Minoshima S
    Clin Nucl Med; 2015 Mar; 40(3):191-4. PubMed ID: 25546191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
    Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
    J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
    [TBL] [